Clinical trial
PROTECT: Prospective Trial on Erythropoietin in Clinical Transplantation
NCT00157300 · Leiden University Medical Center, Other · Completed
Key facts
| NCT number | NCT00157300 |
|---|---|
| Title | PROTECT: Prospective Trial on Erythropoietin in Clinical Transplantation |
| Official title | PROTECT: Prospective Trial on Erythropoietin in Clinical Transplantation |
| Lead sponsor | Leiden University Medical Center, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Patients Receiving a Kidney From a Non-Heart-Beating Donor |
| Intervention type | Drug |
| Interventions | Epoetin beta |
| Enrollment | 92 |
| Start date | Jul 1, 2005 |
| Primary completion | Mar 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | Sep 12, 2005 |
| Last update posted | Aug 2, 2010 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: